Rho Ventures — 2017 Investments

3 investments dated 2017 · listed companies and verified rows first · show all

Convercentconvercent.com in 𝕏Dec 2017Acquired

Convercent provides support services to clients, working with IT specialists and executive teams to solve enterprise problems.

Enterprise SoftwareDenver, US

Patrick Quinlan(Executive Officer, Director)Philip Winterburn(Executive Officer)Chuck Boyle(Executive Officer)

BoardSteven Foster(Director)R. Douglas Higgins(Director)Cameron Lester(Director)

Board seatHabib Kairouz· per SEC Form D

Co-investorsAzure Capital Partners Golub Growth Rho Capital Partners Sapphire Ventures Tola Capital

Cyleracylera.com in 𝕏Jul 2017

Cylera provides a healthcare cybersecurity platform focused on connected medical devices, IoT, and IT assets, giving hospitals and health systems visibility, risk assessment, and threat detection across their environments.

CybersecurityHealthtechIoTNew York, US

Timur Ozekcin(Executive Officer, Director)inSean Abraham(Executive Officer, Director)inApostolos Bakoyiannis(Executive Officer)Owen Wilson(Director)

Co-investorsAlumni Ventures Contour Venture Partners Dreamit Ventures Epsilon Health Investors Frontier Path VC Gaingels +8 more

TiGenixtakeda.com 𝕏Nov 2017Acquired

Takeda is a global pharmaceutical company that develops medicines and treatments for patients, focused on advancing science, technology, and partnerships to create new standards of care.

BiotechHealthtechTokyo, JP

Claudia D'Augusta(Executive Officer)inEduardo Bravo Fernandez de Araoz(Executive Officer, Director)Marie Paule Richard(Executive Officer)inWilfried Dalemans(Executive Officer)

BoardJune Almenoff(Director)Russell Greig(Director)

Co-investorsKleiner Perkins Roche Venture Fund Ysios Capital Brightlands Venture Partners Kreos Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.